Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+30.6%
5Y CAGR+42.7%
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+30.6%/yr
Annual compound
5Y CAGR
+42.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.9x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$97.88M+42.5%
2023$68.68M+19.1%
2022$57.67M+31.4%
2021$43.90M+97.7%
2020$22.21M+34.4%
2019$16.52M+94.3%
2018$8.50M-